The Adenosine A2A-Receptor Antagonist Istradefylline Enhances the Motor Response of l-DOPA Without Worsening Dyskinesia in MPTP-Treated Common Marmosets
The adenosine A2A-receptor antagonist istradefylline decreases OFF time in patients with Parkinson’s disease who are already treated with optimal doses of dopaminergic medication but can cause an increase in non-troublesome dyskinesia. Preclinical experiments have shown that A2A antagonists are most...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2014-01-01
|
| Серія: | Journal of Pharmacological Sciences |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S1347861319301707 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|